Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

11/15/2022
at 12:00 AM PST
06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST

Financial Information

Document Date Description Form View

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

EFFECT

EFFECT View HTML

Form of prospectus reflecting facts events constituting substantive change from last form

424B3 View HTML

Contact
IR

Send us an investor-related question using the form below.